Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Jun;9(6):962-9.
doi: 10.1128/AAC.9.6.962.

Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics

Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics

L D Sabath et al. Antimicrob Agents Chemother. 1976 Jun.

Abstract

The susceptibilities of 36 recent isolates of Staphylococcus aureus and 35 recent isolates of Staphylococcus epidermidis were determined against each of 65 antimicrobial agents and against two of them in combination. Rifampin was the most active of all the agents tested against both S. aureus and S. epidermidis. Among the penicillins, cloxacillin, dicloxacillin, and nafcillin were most active, although benzylpenicillin and phenoxymethyl penicillin were more active against susceptible strains. Cephaloridine was the most active of the cephalosporins, and sisomicin was the most active aminoglycoside. Minocycline was more active than the other tetracycline analogues tested. Among the macrolide-lincomycin compounds in clinical use, clindamycin was more active, and lincomycin was less active than erythromycin. The synergy of trimethoprim-sulfamethoxazole was more striking against S. aureus than against S. epidermidis. The median minimal inhibitory concentrations of the penicillins, cephalosporins, and aminoglycosides were lower against S. aureus, whereas the minimal inhibitory concentrations of the tetracyclines were lower against S. epidermidis.

PubMed Disclaimer

References

    1. Lancet. 1974 Sep 28;2(7883):744-6 - PubMed
    1. Am J Med Sci. 1968 Oct;256(4):255-65 - PubMed
    1. Chemotherapy. 1965-1966;10(6):339-58 - PubMed
    1. Antimicrob Agents Chemother. 1975 Sep;8(3):344-9 - PubMed
    1. Clin Pharmacol Ther. 1970 Mar-Apr;11(2):161-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources